News

Tatva Chintan Pharma Chem Limited informed the BSE Limited and National Stock Exchange of India Limited that its Register of Members and Share Transfer Books will remain closed from September 12, 2026, to September 25, 2026, for the 30th Annual General Meeting scheduled for September 25, 2026, with a record date of September 11, 2026, to determine equity shareholders eligible for the final dividend for Financial Year 2025-26; the company has also fixed September 18, 2026, as the cut-off date for shareholders to vote electronically or attend the AGM.

Tatva Chintan Pharma Chem held the Groundbreaking Ceremony (Bhoomi Pujan) at the new greenfield unit at Dahej - III, Dahej Industrial Estate, Taluka: Vagra, District: Bharuch, Gujarat, India on 20 July 2026.

Net profit of Tatva Chintan Pharma Chem rose 140.30% to Rs 15.98 crore in the quarter ended June 2026 as against Rs 6.65 crore during the previous quarter ended June 2025. Sales rose 42.96% to Rs 167.06 crore in the quarter ended June 2026 as against Rs 116.86 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales167.06116.86 43 OPM %19.3314.83 - PBDT33.0018.07 83 PBT22.439.10 146 NP15.986.65 140 Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 17 July 2026.

Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 16 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.